The Journal of Immunology, Vol 139, Issue 4 1161-1167, Copyright © 1987 by American Association of Immunologists

ARTICLES

Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate

H Holtmann and D Wallach

Binding of radiolabeled tumor necrosis factor (TNF) to cell surface receptors was markedly reduced in human foreskin fibroblasts and cells from SV-80 and HeLa cell lines subsequent to treatment with interleukin 1 (IL-1) or 4 beta-phorbol-12-myristate-13-acetate (PMA). The decrease in TNF binding was initiated within minutes of application of IL-1 or PMA and could not be blocked by cycloheximide, suggesting that it is independent of protein synthesis. Scatchard plot analysis of TNF binding to the SV-80 cells indicated that its decrease in response to IL-1 and PMA reflects a reduced amount of TNF receptors, with no change in their affinity. IL-1 and PMA together had an additive effect on TNF binding. Treatment with TNF did not result in decreased binding of IL-1 to its receptors nor did TNF and IL-1 compete directly for their respective receptors. Human U937 cells on which receptors for IL-1 were below detectable levels exhibited no decrease in TNF binding when treated with IL-1, but did so in response to PMA. In addition to a decrease in TNF receptors, cells treated with IL-1 or PMA exhibited a lesser vulnerability to the cytolytic effect of TNF. The two kinds of changes were not completely correlated. A particularly notable dissimilarity was evident when comparing the rate of their reversal: the TNF receptor level was fully recovered within a few hours of removal of IL-1 or of the water-soluble analogue of PMA, 4 beta-phorbol- 12,13-dibutyrate, from pretreated SV-80 cells; yet at that time resistance to the cytotoxicity of TNF was still prominent. These findings indicate that IL-1 as well as tumor-promoting phorbol diesters can down regulate cellular response to TNF by inducing a decrease in the number of receptors for TNF, and apparently through some other effect(s) as well.

This article has been cited by other articles:

				B. L. Moss, S. Gross, S. T. Gammon, A. Vinjamoori, and D. Piwnica-Worms Identification of a Ligand-induced Transient Refractory Period in Nuclear Factor-{kappa}B Signaling J. Biol. Chem., March 28, 2008; 283(13): 8687 - 8698. [Abstract] [Full Text] [PDF]

				T. H. Elsasser, J. W. Blum, and S. Kahl Characterization of calves exhibiting a novel inheritable TNF-{alpha} hyperresponsiveness to endotoxin: associations with increased pathophysiological complications J Appl Physiol, June 1, 2005; 98(6): 2045 - 2055. [Abstract] [Full Text] [PDF]

				M. Rauchhaus, S. Haehling von Lanzenauer, and A.J.S. Coats Nitric oxide synthase in CHF Eur. Heart J., May 2, 2000; 21(10): 856 - 857. [PDF]

				R. Winzen, S. Kafert, B. P. H. A. Mylius-Spencker, K. Resch, and H. Holtmann Interaction between the mRNA of the 55-kDa Tumor Necrosis Factor Receptor and Cellular Proteins. POSSIBLE INVOLVEMENT IN POST-TRANSCRIPTIONAL REGULATION OF RECEPTOR EXPRESSION J. Biol. Chem., June 7, 1996; 271(23): 13461 - 13467. [Abstract] [Full Text] [PDF]

				J. A. Sánchez-Alcázar, I. Hernández, M.ía P. De la Torre, I. García, E. Santiago, M.ía T. Muñoz-Yagüe, and J. A. Solís-Herruzo Down-regulation of Tumor Necrosis Factor Receptors by Blockade of Mitochondrial Respiration J. Biol. Chem., October 13, 1995; 270(41): 23944 - 23950. [Abstract] [Full Text] [PDF]

				M. P. Boldin, I. L. Mett, E. E. Varfolomeev, I. Chumakov, Y. Shemer-Avni, J. H. Camonis, and D. Wallach Self-association of the ``Death Domains'' of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects J. Biol. Chem., January 6, 1995; 270(1): 387 - 391. [Abstract] [Full Text] [PDF]

				M. I. Block, H. R. Alexander, and J. A. Norton Cholera Toxin Pretreatment Protects Against Tumor Necrosis Factor Lethality Without Compromising Tumor Response to Therapy Arch Surg, November 1, 1992; 127(11): 1330 - 1334. [Abstract] [PDF]

				G. Wong and D. Goeddel Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism Science, November 11, 1988; 242(4880): 941 - 944. [Abstract] [PDF]